tradingkey.logo
tradingkey.logo
Search

Vivos Therapeutics Inc

VVOS
Add to Watchlist
0.157USD
-0.003-1.88%
Close 09-22 16:00ET
2.18MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-1.88%

5 Days

-4.27%

1 Month

-47.14%

6 Months

-87.13%

Year to Date

-92.27%

1 Year

-95.36%

Key Figures

0.159Open
0.169High
33.83KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.23%Turnover Ratio
0.160Prev. Close
0.154Low
5.30KTurnover
LossP/E Static
-0.46P/B
0.00%Div Yield TTM
-138.29%ROA
3.58052wk High
0.02Volume Ratio
-11.14MNet Profit
13.89MShares
-2.1360EPS TTM
6.09Beta
-1528.79%ROE
0.15452wk Low
4.38%Amplitude
47.41%Gross Margin
2.18MMarket Cap
-2.94Reward/Risk
6.01%Risk Rate
Recent
Transcripts
More news coming soon, stay tuned...

Vivos Therapeutics Inc's Score

0.17vs previous score
Forecast7.33
Financial Health6.88
Technical6.84
Valuation Dimensions9.76
Institutional Confidence3.00
Risk Assessment1.71

Media Coverage

Coverage Level

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
2.117Target Price
+1196.98%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy00000000
Buy22222222
Hold11111111
Sell00000000
Strong Sell00000000

Vivos Therapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Strong sell

Summary

Sell

Moving Average

Strong sell

Vivos Therapeutics Inc Latest Earnings Call Transcripts

Vivos Therapeutics (VVOS) Q2 2026 Earnings Call: Revenue Up 35%, Liquidity Risks Persist

Vivos Therapeutics (VVOS) Q2 2026 earnings call: revenue rose 35% to $5.2M as management outlined growth plans amid liquidity and Nasdaq risks.

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.31/-0.39
Revenue / Forecast
5.15M/5.37M

Vivos Therapeutics Inc Profile

SectorHealthcare Equipment & Supplies
Ticker SymbolVVOS
Number of employees109
CountryUnited States of America

Ownership

ShareholdersProportion
V-CO Investors, L.L.C.9.87%
Skaff (Michael C.)9.79%
Luo (Dawei)4.17%
Armistice Capital LLC1.82%
Shareholder TypesProportion
Individual Investor14.52%
Corporation11.54%
Investment Advisor2.63%
Hedge Fund1.85%

FAQs

What is the current price of Vivos Therapeutics Inc (VVOS)?

The current price of Vivos Therapeutics Inc (VVOS) is 0.16.

What is the symbol of Vivos Therapeutics Inc?

The ticker symbol of Vivos Therapeutics Inc is VVOS.

What is the 52-week high of Vivos Therapeutics Inc?

The 52-week high of Vivos Therapeutics Inc is 3.58.

What is the 52-week low of Vivos Therapeutics Inc?

The 52-week low of Vivos Therapeutics Inc is 0.15.

What is the market capitalization of Vivos Therapeutics Inc?

The market capitalization of Vivos Therapeutics Inc is 2.24M.

Is Vivos Therapeutics Inc (VVOS) currently rated as Buy, Hold, or Sell?

According to analysts, Vivos Therapeutics Inc (VVOS) has an overall rating of Buy, with a price target of 2.12.

What is the Earnings Per Share (EPS TTM) of Vivos Therapeutics Inc (VVOS)?

The Earnings Per Share (EPS TTM) of Vivos Therapeutics Inc (VVOS) is -2.14.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.